Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding

Marwan Sheikh-Taha,R. Monroe Crawley

Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding

2019

Marwan Sheikh-Taha
R. Monroe Crawley

Background Clinical experience with using activated prothrombin complex concentrates (aPCCs) to reverse the effects of factor Xa inhibitors is limited.

Keywords:

PROTHROMBIN COMPLEX
Factor Xa Inhibitor
Medicine
Cardiology
Internal medicine
Pharmacology
Diabetes mellitus
Apixaban
Rivaroxaban
in patient
Gastroenterology
major bleeding

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations